Vice President, Research & Development
Adam Standley is an experienced leader in working with digital health systems and is currently the etectRx Vice President of Research & Development. Adam is responsible for setting the direction for the etectRx FDA-cleared ID-Cap System, overseeing the technology in Use Cases and seamless data management and integration across partnerships and in the healthcare ecosystem.
Joining the etectRx team in 2021, Adam brings a deep background in product development for drug delivery, biosensing and combination products to etectRx. Prior to joining etectRx, he served as the Senior Director of Product Development for biotech company Windgap Medical, Inc. He led the design and development of a novel combination product and secured a contract with the National Institute of Health to develop a cyanide antidote autoinjector. Adam spearheaded development of a global supply chain for cGMP device and drug manufacturing, including injection molding, assembly, drug sourcing and powder and liquid fill-finish of a combination product. Preceding his time at Windgap Medical, Inc., Standley founded Arista Solutions LLC, an engineering design consultancy service focused on productizing advanced materials innovations for startups in applications ranging from photovoltaic energy harvesting and nanowire battery technologies, to wearable electronics for biosensing applications.
Adam has a Master of Science from Brown University in Innovation Management & Entrepreneurship and a Bachelor of Science in Aerospace Engineering. He holds 19 active US patents across 7 patent families and has published two peer-reviewed papers in electrodeposition.